NO20042906L - Deutererte, substituerte pyrazolybenzylsulfonamider og medikamenter som inneholder disse forbindelsene - Google Patents

Deutererte, substituerte pyrazolybenzylsulfonamider og medikamenter som inneholder disse forbindelsene

Info

Publication number
NO20042906L
NO20042906L NO20042906A NO20042906A NO20042906L NO 20042906 L NO20042906 L NO 20042906L NO 20042906 A NO20042906 A NO 20042906A NO 20042906 A NO20042906 A NO 20042906A NO 20042906 L NO20042906 L NO 20042906L
Authority
NO
Norway
Prior art keywords
pyrazolybenzylsulfonamides
deuterated
substituted
compounds
drugs containing
Prior art date
Application number
NO20042906A
Other languages
English (en)
Norwegian (no)
Inventor
Rudolf-Giesbert Alken
Original Assignee
Turicum Drug Dev Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Turicum Drug Dev Ag filed Critical Turicum Drug Dev Ag
Publication of NO20042906L publication Critical patent/NO20042906L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20042906A 2001-12-12 2004-07-09 Deutererte, substituerte pyrazolybenzylsulfonamider og medikamenter som inneholder disse forbindelsene NO20042906L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10162121A DE10162121A1 (de) 2001-12-12 2001-12-12 Deuterierte substituierte Pyrazolyl-Benzolsulfonamide sowie diese Verbindungen enthaltende Arzneimittel
PCT/DE2002/004600 WO2003050091A1 (de) 2001-12-12 2002-12-11 Deuterierte substituierte pyrazolyl-benzolsulfonamide sowie diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
NO20042906L true NO20042906L (no) 2004-07-09

Family

ID=7709640

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042906A NO20042906L (no) 2001-12-12 2004-07-09 Deutererte, substituerte pyrazolybenzylsulfonamider og medikamenter som inneholder disse forbindelsene

Country Status (14)

Country Link
US (1) US20050222238A1 (is)
EP (1) EP1456179A1 (is)
JP (1) JP2005516009A (is)
CN (1) CN1612863A (is)
AU (1) AU2002357973A1 (is)
CA (1) CA2471743A1 (is)
DE (1) DE10162121A1 (is)
HU (1) HUP0402422A2 (is)
IL (1) IL162432A0 (is)
IS (1) IS7304A (is)
NO (1) NO20042906L (is)
PL (1) PL370563A1 (is)
RU (1) RU2004121033A (is)
WO (1) WO2003050091A1 (is)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006274037B2 (en) * 2005-07-26 2012-04-26 Takeda Gmbh Isotopically substituted pantoprazole
CA2615670C (en) * 2005-07-26 2015-01-20 Nycomed Gmbh Isotopically substituted proton pump inhibitors
US7601737B2 (en) * 2005-07-26 2009-10-13 Nycomed Gmbh Isotopically substituted proton pump inhibitors
CN101309917B (zh) * 2005-10-06 2013-09-11 奥斯拜客斯制药有限公司 具有增强治疗性质的胃h+，k+-atp酶氘代抑制剂
US20070287734A1 (en) * 2006-06-09 2007-12-13 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted pyrazole compounds with cannabinoid receptor activity
WO2008070619A1 (en) * 2006-12-04 2008-06-12 Auspex Pharmaceuticals, Inc. Deuterated oxazolidinones and their use as antibiotics
WO2008073863A2 (en) * 2006-12-08 2008-06-19 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted allylamines
US20080299216A1 (en) * 2007-06-01 2008-12-04 Protia, Llc Deuterium-enriched aripiprazole
US20090209608A1 (en) * 2007-08-29 2009-08-20 Protia, Llc Deuterium-enriched asenapine
US20090062364A1 (en) * 2007-08-29 2009-03-05 Protia, Llc Deuterium-enriched celecoxib
US20090062185A1 (en) * 2007-08-29 2009-03-05 Protia, Llc Deuterium-enriched anidulafungin
US20090069219A1 (en) * 2007-09-09 2009-03-12 Protia, Llc Deuterium-enriched telavancin
US20090076158A1 (en) * 2007-09-13 2009-03-19 Protia, Llc Deuterium-enriched bicalutamide
US20090075870A1 (en) * 2007-09-17 2009-03-19 Protia, Llc Deuterium-enriched caspofungin
US20090082419A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched tegaserod
US20100120756A1 (en) * 2008-09-17 2010-05-13 Auspex Pharmaceuticals, Inc. Phenothiazine modulators of h1 receptors
US8227451B2 (en) * 2008-11-12 2012-07-24 Auspex Pharmaceuticals Phenylacetic acid inhibitors of cyclooxygenase
AR075584A1 (es) 2009-02-27 2011-04-20 Intermune Inc COMPOSICIONES TERAPEUTICAS QUE COMPRENDEN beta-D-2'-DESOXI-2'-FLUORO-2'-C-METILCITIDINA Y UN DERIVADO DE ACIDO ISOINDOL CARBOXILICO Y SUS USOS. COMPUESTO.
US20120244122A1 (en) * 2009-05-28 2012-09-27 Masse Craig E Peptides for the Treatment of HCV Infections
MX2012003171A (es) * 2009-09-28 2012-04-11 Hoffmann La Roche Novedosos inhibidores macrociclicos de la replicacion del virus de hepatitis c.
US20150031768A1 (en) * 2011-08-19 2015-01-29 The Trustees Of Princeton University C-halogen bond formation
IL305990B2 (en) 2013-12-03 2025-12-01 Intra Cellular Therapies Inc Long-acting injectable composition comprising polymeric microspheres of heterocycle fused gamma-carboline compounds or a pharmaceutical composition for sustained or delayed release comprising the compounds and their use in the treatment of bipolar disorder i and/or bipolar ii disorder
MX365969B (es) * 2014-04-04 2019-06-21 Intra Cellular Therapies Inc Gamma-carbolinas fusionadas con heterociclos sustituidas con deuterio.
PL3407889T3 (pl) 2016-03-25 2021-11-22 Intra-Cellular Therapies, Inc. Związki organiczne i ich zastosowanie w leczeniu lub zapobieganiu zaburzeniom ośrodkowego układu nerwowego
US11331316B2 (en) 2016-10-12 2022-05-17 Intra-Cellular Therapies, Inc. Amorphous solid dispersions
IL268970B2 (en) 2017-03-24 2023-12-01 Intra Cellular Therapies Inc Oral transmucosal formulations of substituted heterocycle fused gamma carbolines
EP3843729A4 (en) 2018-08-29 2022-06-01 Intra-Cellular Therapies, Inc. NOVEL COMPOSITIONS AND PROCESSES
CA3108558A1 (en) 2018-08-31 2020-03-05 Intra-Cellular Therapies, Inc. Novel methods
CN112584837A (zh) 2018-08-31 2021-03-30 细胞内治疗公司 新方法
JP7673040B2 (ja) 2019-07-07 2025-05-08 イントラ－セルラー・セラピーズ・インコーポレイテッド 新規方法
US20230158000A1 (en) * 2020-12-28 2023-05-25 Holy Haid Lab Corp Pharmaceutical composition for treating or preventing viral hepatitis and the use thereof
US12414948B2 (en) 2022-05-18 2025-09-16 Intra-Cellular Therapies, Inc. Methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2141916T3 (es) * 1993-11-30 2000-04-01 Searle & Co Pirazolil-bencenosulfonamidas sustituidas para el tratamiento de la inflamacion.
US5466823A (en) * 1993-11-30 1995-11-14 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides
PT1104760E (pt) * 1999-12-03 2003-06-30 Pfizer Prod Inc Compostos de sulfamoil-heteroarilpirazole como agentes analgesicos e anti-inflamatorios

Also Published As

Publication number Publication date
IL162432A0 (en) 2005-11-20
CN1612863A (zh) 2005-05-04
PL370563A1 (en) 2005-05-30
HUP0402422A2 (hu) 2005-03-29
WO2003050091A1 (de) 2003-06-19
US20050222238A1 (en) 2005-10-06
JP2005516009A (ja) 2005-06-02
EP1456179A1 (de) 2004-09-15
DE10162121A1 (de) 2003-06-18
RU2004121033A (ru) 2006-01-10
AU2002357973A1 (en) 2003-06-23
CA2471743A1 (en) 2003-06-19
IS7304A (is) 2004-06-10

Similar Documents

Publication Publication Date Title
NO20042906L (no) Deutererte, substituerte pyrazolybenzylsulfonamider og medikamenter som inneholder disse forbindelsene
NO20042084L (no) 6-hydroksyisoflavoner, derivater og legemidler som omfatter disse
NO20042907L (no) Deutererte, substituerte dihydrofuranoner og medikamenter som inneholder disse forbindelsene
DK1572707T3 (da) Hidtil ukendte aromatiske fluorglycosidderivater, lægemidler indeholdende disse forbindelser og anvendelse heraf
NO20032733L (no) Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene og deres anvendelse
NL1021822A1 (nl) Tamsulosinetabletten.
DK1534277T3 (da) Acylerede, heteroaryl-kondenserede cycloalkenylaminer og anvendelse af disse som lægemidler
DK1401806T3 (da) Benzoylsulfonamider og sulfonylbenzamidiner til anvendelse som antitumormidler
ATE389392T1 (de) Paracetamol enthaltende tablette
ATE434435T1 (de) Pharmazeutische zubereitungen enthaltend modafinil
IS7798A (is) Efnasambönd, lyfjablöndur og aðferðir
NO20035798L (no) Tablett som inneholder cetirizin og pseudoefedrin
NO20042337L (no) Deutererte pyrazolopyimidinoner sa vel som legemidler som inneholder disse forbindelser
DK1215213T3 (da) Bicylliske aminopyrazinonderivater, fremstilling deraf og farmaceutiske sammensætninger, som indeholder disse
NO20013816D0 (no) Benzamidderivater og legemidler som inneholder disse
DK1299373T3 (da) Cykliske substituerede aminomethylforbindelser og lægemidler indeholdnede disse forbindelser
FI5009U1 (fi) Tabletti
UA4793S (uk) Пляшка
UA5683S (uk) Пляшка
UA4871S (uk) Пляшка
UA4872S (uk) Пляшка
UA4940S (uk) Пляшка
UA4976S (uk) Пляшка
UA5043S (uk) Пляшка
UA5100S (uk) Пляшка

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application